| scholarly article | Q13442814 |
| P2093 | author name string | Yong Yang | |
| Yu-Jing Zhang | |||
| Ying Wang | |||
| Yuan Zhu | |||
| Bo Chen | |||
| Tao Wu | |||
| Gang Wu | |||
| Mei Shi | |||
| Xia He | |||
| Ye-Xiong Li | |||
| Hang Su | |||
| Jian-Zhong Cao | |||
| Li-Ming Xu | |||
| Wei-Xin Liu | |||
| Zhi-Yong Yuan | |||
| Jun-Xin Wu | |||
| Li-Ting Qian | |||
| Su-Yu Zhu | |||
| Li-Ling Zhang | |||
| Bao-Lin Qu | |||
| Fu-Quan Zhang | |||
| Sheng-Min Lan | |||
| Shu-Nan Qi | |||
| Xiao-Rong Hou | |||
| P2860 | cites work | A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project | Q28251216 |
| A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma | Q28254924 | ||
| Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project | Q33382121 | ||
| SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. | Q33402956 | ||
| Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study | Q34479889 | ||
| Impact of age at diagnosis on prostate cancer treatment and survival | Q34679220 | ||
| smoothHR: an R package for pointwise nonparametric estimation of hazard ratio curves of continuous predictors | Q37422476 | ||
| The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States. | Q38852466 | ||
| Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma | Q39022039 | ||
| Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan. | Q39052534 | ||
| Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. | Q39082097 | ||
| A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis | Q39999898 | ||
| Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability | Q41001574 | ||
| Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study | Q41387447 | ||
| Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma | Q41750668 | ||
| Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors | Q42175789 | ||
| Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents | Q43265366 | ||
| Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patients. | Q46889433 | ||
| Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study | Q47435348 | ||
| Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma | Q48566120 | ||
| Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. | Q50960230 | ||
| Unfavorable prognosis of elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma. | Q53171649 | ||
| Follicular lymphoma international prognostic index. | Q53289840 | ||
| Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG) | Q57790416 | ||
| Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group | Q58705127 | ||
| Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study | Q61774252 | ||
| Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma | Q82107025 | ||
| Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma | Q82798869 | ||
| Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma | Q83215929 | ||
| Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG) | Q88607896 | ||
| Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States | Q88645165 | ||
| P433 | issue | 19 | |
| P921 | main subject | extranodal NK/T-cell lymphoma, nasal type | Q4763254 |
| P304 | page(s) | 8463-8473 | |
| P577 | publication date | 2019-10-06 | |
| P1433 | published in | Aging | Q2845875 |
| P1476 | title | Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG) | |
| P478 | volume | 11 |
| Q97557982 | First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG |
| Q99565873 | The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non-small cell lung cancer receiving chemoradiotherapy |
Search more.